Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report

Medullary thyroid carcinoma (MTC) with high proliferative potential or tumor necrosis is classified as high-grade MTC. Progression from low- to high-grade MTC has rarely been documented. We report a case in which a sporadic MTC transitioned from low- to high-grade after the initial therapy. A 62-year-old man with low-grade MTC underwent total thyroidectomy and bilateral neck dissection. Recurrence was identified postoperatively, and the surgical specimen of the lymph node revealed metastatic MTC with high-grade features. Treatment was initiated with vandetanib followed by selpercatinib, with no significant efficacy. Debulking surgery was performed for five recurrent lesions. Surgical specimens of the tumor after chemotherapy showed increased aggression, characterized by high Ki-67 index and decreased calcitonin expression. The patient eventually died due to brain metastasis. This case highlights the potential for MTC to progress from low- to high-grade and underscores the importance of ongoing evaluations for recurrent disease.

Authors

Institutions

Publication Details

Journal
Pathology International
Published
2026-02-01
DOI
https://doi.org/10.1111/pin.70089
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report

Masaomi Sen, Atsuko Sakanushi, Takeshi Abe, Yukako Shintani‐Domoto et al.
Pathology International
Thyroid Cancer Diagnosis and Treatment
article

Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report

Masaomi Sen, Atsuko Sakanushi, Takeshi Abe, Yukako Shintani‐Domoto, Iwao Sugitani, Marie Saito, Takenori Fujii, Tomoo Jikuzono, Mami Matsui, Ryuji Ohashi, Hiroko Kazusaka, Ryuta Nagaoka, Ryo Ito
article en

Abstract

Medullary thyroid carcinoma (MTC) with high proliferative potential or tumor necrosis is classified as high-grade MTC. Progression from low- to high-grade MTC has rarely been documented. We report a case in which a sporadic MTC transitioned from low- to high-grade after the initial therapy. A 62-year-old man with low-grade MTC underwent total thyroidectomy and bilateral neck dissection. Recurrence was identified postoperatively, and the surgical specimen of the lymph node revealed metastatic MTC with high-grade features. Treatment was initiated with vandetanib followed by selpercatinib, with no significant efficacy. Debulking surgery was performed for five recurrent lesions. Surgical specimens of the tumor after chemotherapy showed increased aggression, characterized by high Ki-67 index and decreased calcitonin expression. The patient eventually died due to brain metastasis. This case highlights the potential for MTC to progress from low- to high-grade and underscores the importance of ongoing evaluations for recurrent disease.

Pathology InternationalVol. 76(2)
Nippon Medical School Hospital (JP), Nippon Medical School (JP)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Good health and well-being
Openalex Percentile: Top 71%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.